These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 30039423)

  • 1. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
    Erol I; Aksoydan B; Kantarcioglu I; Durdagi S
    Methods Mol Biol; 2018; 1824():431-448. PubMed ID: 30039423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
    ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand binding determinants for angiotensin II type 1 receptor from computer simulations.
    Matsoukas MT; Cordomí A; Ríos S; Pardo L; Tselios T
    J Chem Inf Model; 2013 Nov; 53(11):2874-83. PubMed ID: 24090110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of multiscale simulations on GPCRs.
    Durdagi S; Dogan B; Erol I; Kayık G; Aksoydan B
    Curr Opin Struct Biol; 2019 Apr; 55():93-103. PubMed ID: 31082696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled Receptor.
    Kellici TF; Ntountaniotis D; Kritsi E; Zervou M; Zoumpoulakis P; Potamitis C; Durdagi S; Salmas RE; Ergun G; Gokdemir E; Halabalaki M; Gerothanassis IP; Liapakis G; Tzakos A; Mavromoustakos T
    Curr Med Chem; 2016; 23(1):36-59. PubMed ID: 26572611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
    Bhunia SS; Saxena AK
    Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II Type 1 Receptor Homology Models: A Comparison Between In Silico and the Crystal Structures.
    Kellici TF
    Methods Mol Biol; 2018; 1824():449-460. PubMed ID: 30039424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan binding.
    Patny A; Desai PV; Avery MA
    Proteins; 2006 Dec; 65(4):824-42. PubMed ID: 17034041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple templates-based homology modeling enhances structure quality of AT1 receptor: validation by molecular dynamics and antagonist docking.
    Sokkar P; Mohandass S; Ramachandran M
    J Mol Model; 2011 Jul; 17(7):1565-77. PubMed ID: 20924625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into AT1 receptor activation through AngII binding studies.
    Matsoukas MT; Potamitis C; Plotas P; Androutsou ME; Agelis G; Matsoukas J; Zoumpoulakis P
    J Chem Inf Model; 2013 Nov; 53(11):2798-811. PubMed ID: 24053563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPCR Homology Model Generation for Lead Optimization.
    Tautermann CS
    Methods Mol Biol; 2018; 1705():115-131. PubMed ID: 29188560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARg.
    Zhang J; Hao QQ; Liu X; Jing Z; Jia WQ; Wang SQ; Xu WR; Cheng XC; Wang RL
    Oncotarget; 2017 Apr; 8(15):25612-25627. PubMed ID: 28445965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational methods for studying G protein-coupled receptors (GPCRs).
    Kaczor AA; Rutkowska E; Bartuzi D; Targowska-Duda KM; Matosiuk D; Selent J
    Methods Cell Biol; 2016; 132():359-99. PubMed ID: 26928552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships.
    Naqvi AAT; Mohammad T; Hasan GM; Hassan MI
    Curr Top Med Chem; 2018; 18(20):1755-1768. PubMed ID: 30360721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise.
    Yarnitzky T; Levit A; Niv MY
    Curr Opin Drug Discov Devel; 2010 May; 13(3):317-25. PubMed ID: 20443165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural determinants of subtype selectivity and functional activity of angiotensin II receptors.
    Sallander J; Wallinder C; Hallberg A; Åqvist J; Gutiérrez-de-Terán H
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1355-9. PubMed ID: 26810314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding electrostatic and steric requirements related to hypertensive action of AT(1) antagonists using molecular modeling techniques.
    da C Silva D; Maltarollo VG; de Lima EF; Weber KC; Honorio KM
    J Mol Model; 2014 Jul; 20(7):2231. PubMed ID: 24935104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Novel Multi-target Inhibitor of angiotensin type 1 receptor and neprilysin inhibitors from Traditional Chinese Medicine.
    Huo X; Qiao L; Chen Y; Chen X; He Y; Zhang Y
    Sci Rep; 2019 Nov; 9(1):16205. PubMed ID: 31700033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Computational Techniques to Study GPCR-Ligand Recognition.
    Ciancetta A; Sabbadin D; Federico S; Spalluto G; Moro S
    Trends Pharmacol Sci; 2015 Dec; 36(12):878-890. PubMed ID: 26538318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.